TOKYO--(BUSINESS WIRE)--Elix, Inc., an AI drug discovery company with the mission of “Rethinking Drug Discovery” (CEO: Shinya Yuki/Headquarters: Tokyo; hereafter referred to as "Elix") commenced joint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback